These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8708368)

  • 21. Japanese encephalitis - prevention in travellers.
    Mayer CA; Neilson AA
    Aust Fam Physician; 2010 Jun; 39(6):389-94. PubMed ID: 20628677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
    Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
    Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Japanese encephalitis vaccine and adverse effects among travellers.
    Robinson HC; Russell ML; Csokonay WM
    Can Dis Wkly Rep; 1991 Aug; 17(32):173-4, 177. PubMed ID: 1657420
    [No Abstract]   [Full Text] [Related]  

  • 30. When should travelers from nonendemic areas for flaviviruses receive booster vaccination for Japanese encephalitis?
    Kitchener S; Baade L; Brennan L
    J Travel Med; 2003; 10(1):50-1. PubMed ID: 12729513
    [No Abstract]   [Full Text] [Related]  

  • 31. Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines?
    Bock HL; Kruppenbacher JP; Bienzle U; De Clercq NA; Hofmann F; Clemens RL
    J Travel Med; 2000; 7(2):74-8. PubMed ID: 10759573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flavivirus infections: yellow fever, dengue fever and Japanese encephalitis].
    Buhl MR
    Ugeskr Laeger; 2005 Oct; 167(43):4076-80. PubMed ID: 16251091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
    Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
    Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
    Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
    Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-Term Immunogenicity and Safety of an Accelerated Pre-Exposure Prophylaxis Regimen With Japanese Encephalitis Vaccine in Combination With a Rabies Vaccine: A Phase III, Multicenter, Observer-Blind Study.
    Jelinek T; Burchard GD; Dieckmann S; Bühler S; Paulke-Korinek M; Nothdurft HD; Reisinger E; Ahmed K; Bosse D; Meyer S; Costantini M; Pellegrini M
    J Travel Med; 2015; 22(4):225-31. PubMed ID: 25997707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.
    Jelinek T; Cramer JP; Dieckmann S; Hatz C; Paulke-Korinek M; Alberer M; Reisinger EC; Costantini M; Gniel D; Bosse D; Lattanzi M
    Travel Med Infect Dis; 2015; 13(3):241-50. PubMed ID: 26005163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
    Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
    Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
    Guo W; Li L; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of patients with diabetes mellitus--a retrospective study.
    Mad'ar R; Benesová D; Brandejská D; Cermáková M; Dvorková A; Gazárková O; Jakubalová S; Kochová I; Lastovicková J; Nebáznivá D; Orolinová M; Polomis K; Rehka V; Sattranová L; Schejbalová M; Slámová A; Skalleová D; Sevcíková H; Tkadlecová H; Tmejová M; Trmal J; Turková D
    Cent Eur J Public Health; 2011 Jun; 19(2):98-101. PubMed ID: 21739900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.